THERE'S AN ALTERNATIVE TO WARFARIN
FOR PEOPLE WHO NEED ONE. IT'S CALLED WATCHMAN™.
A one-time procedure that effectively reduces the risk of stroke in patients with non-valvular atrial fibrillation.
See How It Works
IT TAKES IMAGINATION
TO MAKE
SCIENCE MORE
EFFICIENT
That’s the difference between making devices and making progress.
Get to Know Us
Healthcare Professionals
Explore our breakthrough products that make a meaningful difference in patient's lives.
Administrators
Discover resources for Cardiovascular, Gastroenterology and Urology administrators.
Patients & Caregivers
Learn about living with an implanted device, explore health conditions and treatment options, and get support.
Patient Stories
Rewarding Careers
Improving Health
Advance your career. Work at the foremost of medical innovation. And make a meaningful impact on lives around the globe.
Life-Changing Ideas
Wanted
We're always looking for groundbreaking ideas for new products or ways to improve existing ones.
Doing Business the
Right Way
Discover our commitment to doing business sustainably and responsibly in communities around the world.
2019 Annual Meeting
of Stockholders
Our 2019 Annual Meeting of Stockholders will take place on Thursday, May 9, 2019.
News
Boston Scientific Announces Conference Call Discussing First Quarter 2019 Financial Results
Late-breaking Clinical Trial Highlights Positive Safety and Efficacy Data for the LUMINIZE™ RF Balloon Catheter
Boston Scientific Receives CE Mark for Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device
Boston Scientific Announces Scheduled Data at EHRA 2019 Congress
Boston Scientific to Participate in the Cowen and Company 39th Annual Healthcare Conference
Boston Scientific Prices $4.3 Billion of Senior Notes
Boston Scientific to Participate in the 8th Annual SVB Leerink Global Healthcare Conference